Halozyme Therapeutics is a company that changed trajectory during 2026. It entered the year as a biologics‑delivery specialist but is a royalty compounder.

Dateline Resources (ASX:DTR) loses its stay bid as the Colosseum injunction heads to the Ninth Circuit, with the US Government backing the appeal.

QMines (ASX:QML) raises A$5.5 million at 5.2 cents in a placement backed by QIC, strengthening funding for the Mt Chalmers DFS and drilling.

Janus Electric (ASX:JNS) lodges 16 more California HVIP applications as US conversion coverage expands to 920 Class 8 truck configurations.

Anthropic IPO filing reveals US$895 billion in AI commitments, US$17 billion quarterly revenue and a US$23.3 billion net loss. What investors should know.

Reedy Lagoon (ASX:RLC) seeks shareholder approval for Tranche 2 of a A$700,000 placement priced at A$0.00125, lifting share count by 25%.

Another RBA rate hike, the 5th (!) this year, and it may still not be enough to reign in the effects of Labor's excessive spending ... thanks Chalmers!

Oracle (ORCL) stock fell nearly 7% intraday as its US$20 billion AI financing plan raised dilution fears. Explore the share sale, debt risks and cash flow outlook.

Marvell (MRVL) stock plunged 10% after announcing a US$115 billion Lumentum AI deal. See the acquisition terms, shareholder dilution and investor concerns.

Skylark Minerals (ASX:SKM) raised A$20m at a premium with PDI Gold taking a 9.9% strategic stake ahead of 2027 Zaranou ...

AMA Group (ASX:AMA) reinstates its first dividend since 2019 and reaffirms FY27 EBITDA guidance of A$75-80m after a softer ...